The 2024 Guidelines for Osteoporosis - Korean Society of Menopause

키워드

참고문헌 (95)

1. Kanis JA, "The diagnosis of osteoporosis", J Bone Miner Res, 9, pp.1137~1141 (1994)
2. "Osteoporosis prevention, diagnosis, and therapy", NIH Consens Statement, 17, pp.1~45 (2000)
3. Riggs BL, "Sex steroids and the construction and conservation of the adult skeleton", Endocr Rev, 23, pp.279~302 (2002)
4. Guideline for osteoporosis with fractures, , The Korean Society of Osteoporosis, Korea Womenʼs Health and osteoporosis foundation, ~ (2021)
5. Physicianʼs guide for osteoporosis, , The Korean Society for Bone and Mineral Research, ~ (2020)
6. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis, , WHO, 1~129, pp.World Health Organ Tech Rep Ser 843 (1994)
7. Hernlund E, "Osteoporosis in the European Union : medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation(IOF)and the European Federation of Pharmaceutical Industry Associations(EFPIA)", Arch Osteoporos, 8, pp.136~ (2013)
8. Burge R, "Incidence and economic burden of osteoporosisrelated fractures in the United States, 2005-2025", J Bone Miner Res, 22, pp.465~475 (2007)
9. Choi SH, "Incidence and management trends of osteoporotic vertebral compression fractures in South Korea : a nationwide population-based study", Asian Spine J, 14, pp.220~228 (2020)
10. Lee YK, "Epidemiology of osteoporosis and osteoporotic fractures in South Korea", Endocrinol Metab (Seoul), 28, pp.90~93 (2013)
11. Osteoporosis and osteoporotic fractures fact sheet, "The Korean Society for Bone and Mineral Research (KSBMR)", KSBMR, ~ (2019)
12. Siris ES, "Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women : results from the National Osteoporosis Risk Assessment", JAMA, 286, pp.2815~2822 (2001)
13. Siris ES, "Bone mineral density thresholds for pharmacological intervention to prevent fractures", Arch Intern Med, 164, pp.1108~1112 (2004)
14. The Korean Society of Osteoporosis, "Manual of bone densitometry", The Korean Society of Osteoporosis, ~ (2018)
15. Licata AA, "A DXA primer for the practicing clinician:a case-based manual for understanding and interpreting bone densitometry" (2013), Springer Science & Business Media
16. Saag KG, "Diagnosis and management of osteoporosis" (2013), Professional Communications
17. Garnero P, "Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women : the OFELY prospective study", J Bone Miner Res, 17, pp.826~833 (2002)
18. Park SY, "Position statement on the use of bone turnover markers for osteoporosis treatment", J Bone Metab, 26, pp.213~224 (2019)
19. Garnero P, "Markers of bone resorption predict hip fracture in elderly women : the EPIDOS Prospective Study", J Bone Miner Res, 11, pp.1531~1538 (1996)
20. Vergnaud P, "Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women : the EPIDOS Study", J Clin Endocrinol Metab, 82, pp.719~724 (1997)
21. Marques EA, "Association of bone turnover markers with volumetric bone loss, periosteal apposition, and fracture risk in older men and women : the AGES-Reykjavik longitudinal study", Osteoporos Int, 27, pp.3485~3494 (2016)
22. Melton LJ 3rd, "Relative contributions of bone density, bone turnover, and clinical risk factors to long-term fracture prediction", J Bone Miner Res, 18, pp.312~318 (2003)
23. Naylor KE, "Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis : the TRIO study", Osteoporos Int, 27, pp.21~31 (2016)
24. Miller PD, "Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates", J Clin Endocrinol Metab, 101, pp.3163~3170 (2016)
25. Bone HG, "10 years of denosumab treatment in postmenopausal women with osteoporosis : results from the phase 3randomised FREEDOM trial and open-label extension", Lancet Diabetes Endocrinol, 5, pp.513~523 (2017)
26. Lamy O, "Severe rebound-associated vertebral fractures after denosumab discontinuation : 9 clinical cases report", J Clin Endocrinol Metab, 102, pp.354~358 (2017)
27. Finkelstein JS, "Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men", J Clin Endocrinol Metab, 91, pp.2882~2887 (2006)
28. Glover SJ, "Rapid and robust response of biochemical markers of bone formation to teriparatide therapy", Bone, 45, pp.1053~1058 (2009)
29. Eastell R, "Development of an algorithm for using PINP to monitor treatment of patients with teriparatide", Curr Med Res Opin, 22, pp.61~66 (2006)
30. McClung MR, "Romosozumab in postmenopausal women with low bone mineral density", N Engl J Med, 370, pp.412~420 (2014)
31. Delmas PD, "Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis", J Clin Endocrinol Metab, 92, pp.1296~1304 (2007)
32. Diez-Perez A, "Treatment failure in osteoporosis", Osteoporos Int, 23, pp.2769~2774 (2012)
33. Wu CH, "Consensus statement on the use of bone turnover markers for short-term monitoring of osteoporosis treatment in the Asia-Pacific region", J Clin Densitom, 24, pp.3~13 (2021)
34. Iizuka Y, "Bone turnover markers and the factors associated with atypical femur fractures among Japanese patients", Injury, 47, pp.2484~2489 (2016)
35. Bonnick SL, "Monitoring osteoporosis therapy : bone mineral density, bone turnover markers, or both?", Am J Med, 119(4 Suppl 1), pp.S25~S31 (2006)
36. Wasnich RD, "Antifracture efficacy of antiresorptive agents are related to changes in bone density", J Clin Endocrinol Metab, 85, pp.231~236 (2000)
37. Cummings SR, "Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs", Am J Med, 112, pp.281~289 (2002)
38. Camacho PM, "American Association of Clinical Endocrinologists", American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020update, 2020, pp.26(Suppl 1), 1~46
39. McClung M, "Bisphosphonate therapy for osteoporosis : benefits, risks, and drug holiday", Am J Med, 126, pp.13~20 (2013)
40. Lee CY, "CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part I : biological concepts with a review of the literature", Implant Dent, 18, pp.492~500 (2009)
41. Lee CY, "CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II : a prospective clinical study", Implant Dent, 19, pp.29~38 (2010)
42. "Management of osteoporosis in postmenopausal women: the 2021position statement of The North American Menopause Society", Menopause, 28, pp.973~997 (2021)
43. Cummings SR, "Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group", Lancet, 341, pp.72~75 (1993)
44. Kanis JA, "Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds", Osteoporos Int, 12, pp.989~995 (2001)
45. Kanis JA, "Assessment of fracture risk", Osteoporos Int, 16, pp.581~589 (2005)
46. Vestergaard P, "Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis", Osteoporos Int, 18, pp.427~444 (2007)
47. Kanis JA, "Development and use of FRAX in osteoporosis", Osteoporos Int, 21(Suppl 2), pp.S407~S413 (2010)
48. Watts NB, "National Osteoporosis Foundation 2008 Clinicianʼs Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool(FRAX) : what they mean to the bone densitometrist and bone technologist", J Clin Densitom, 11, pp.473~477 (2008)
49. Nassar K, "Added value of trabecular bone score over bone mineral density for identification of vertebral fractures in patients with areal bone mineral density in the non-osteoporotic range", Osteoporos Int, 25, pp.243~249 (2014)
50. McCloskey EV, "Adjusting fracture probability by trabecular bone score", Calcif Tissue Int, 96, pp.500~509 (2015)
51. Leslie WD, "Construction and validation of a simplified fracture risk assessment tool for Canadian women and men : results from the CaMos and Manitoba cohorts", Osteoporos Int, 22, pp.1873~1883 (2011)
52. Papaioannou A, "2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada : summary", CMAJ, 182, pp.1864~1873 (2010)
53. The North American Menopause Society, "Menopause practice: a clinicianʼs guide" (2019), The North American Menopause Society
54. U.S. Preventive Services Task Force, "Screening for osteoporosis:U.S. preventive services task force recommendation statement", Ann Intern Med, 154, pp.356~364 (2011)
55. Eastell R, "Pharmacological management of osteoporosis in postmenopausal women : an Endocrine Society* clinical practice guideline", J Clin Endocrinol Metab, 104, pp.1595~1622 (2019)
56. Kanis JA, "Characteristics of recurrent fractures", Osteoporos Int, 29, pp.1747~1757 (2018)
57. Chlebowski RT, "Calcium plus vitamin D supplementation and the risk of breast cancer", J Natl Cancer Inst, 100, pp.1581~1591 (2008)
58. Wactawski-Wende J, "Calcium plus vitamin D supplementation and the risk of colorectal cancer", N Engl J Med, 354, pp.684~696 (2006)
59. Kahwati LC, "Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in communitydwelling adults : evidence report and systematic review for the US preventive services task force", JAMA, 319, pp.1600~1612 (2018)
60. Viswanathan M, "Screening to prevent osteoporotic fractures : updated evidence report and systematic review for the US preventive services task force", JAMA, 319, pp.2532~2551 (2018)
61. Michaëlsson K, "Long term calcium intake and rates of all cause and cardiovascular mortality : community based prospective longitudinal cohort study", BMJ, 346, pp.f228~ (2013)
62. "Osteoporosis prevention, screening, and diagnosis: ACOG clinical practice guideline no. 1", Obstet Gynecol, 138, pp.494~506 (2021)
63. Manson JE, "Vitamin D supplements and prevention of cancer and cardiovascular disease", N Engl J Med, 380, pp.33~44 (2019)
64. Rabenberg M, "Implications of standardization of serum 25-hydroxyvitamin D data for the evaluation of vitamin D status in Germany, including a temporal analysis", BMC Public Health, 18, pp.845~ (2018)
65. Guirguis-Blake JM, "Interventions to prevent falls in older adults : updated evidence report and systematic review for the US preventive services task force", JAMA, 319, pp.1705~1716 (2018)
66. LeBoff MS, "VITamin D and OmegA-3 TriaL(VITAL) : effects of vitamin D supplements on risk of falls in the US population", J Clin Endocrinol Metab, 105, pp.2929~2938 (2020)
67. Krist AH, "Screening for vitamin D deficiency in adults : US preventive services task force recommendation statement", JAMA, 325, pp.1436~1442 (2021)
68. Sempos CT, "Vitamin D status as an international issue : national surveys and the problem of standardization", Scand J Clin Lab Invest Suppl, 243, pp.32~40 (2012)
69. Binkley N, "Standardizing vitamin D assays : the way forward", J Bone Miner Res, 29, pp.1709~1714 (2014)
70. Scragg R, "Monthly high-dose vitamin D supplementation and cancer risk : a post hoc analysis of the vitamin D assessment randomized clinical trial", JAMA Oncol, 4, pp.e182178~ (2018)
71. The Korean Society for Bone and Mineral Research (KSBMR), "Textbook of osteoporosis" (2016), KSBMR
72. Rizzoli R, "Benefits and safety of dietary protein for bone health-an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation", Osteoporos Int, 29, pp.1933~1948 (2018)
73. Bonjour JP, "Protein intake and bone health", Int J Vitam Nutr Res, 81, pp.134~142 (2011)
74. Compston J, "UK clinical guideline for the prevention and treatment of osteoporosis", Arch Osteoporos, 12, pp.43~ (2017)
75. Heaney RP, "Amount and type of protein influences bone health", Am J Clin Nutr, 87, pp.1567~ (2008)
76. Myint MW, "Clinical benefits of oral nutritional supplementation for elderly hip fracture patients : a single blind randomised controlled trial", Age Ageing, 42, pp.39~45 (2013)
77. Movassagh EZ, "Current evidence on the association of dietary patterns and bone health : a scoping review", Adv Nutr, 8, pp.1~16 (2017)
78. Kwon SJ, "High dietary sodium intake is associated with low bone mass in postmenopausal women : Korea National Health and Nutrition Examination Survey, 2008-2011", Osteoporos Int, 28, pp.1445~1452 (2017)
79. National health survey: The 7th Korea National Health and Nutrition Examination Survey, "Korea Centers for Disease Control and Prevention", Korea Centers for Disease Control and Prevention, ~ (2019)
80. Tucker KL, "Colas, but not other carbonated beverages, are associated with low bone mineral density in older women : The Framingham Osteoporosis Study", Am J Clin Nutr, 84, pp.936~942 (2006)
81. Dietary reference intakes for Koreans, "The Korean Nutrition Society", Ministry of Health and Welfare; The Korean Nutrition Society, ~ (2015)
82. Shearer MJ, "Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification", Curr Opin Clin Nutr Metab Care, 3, pp.433~438 (2000)
83. Lagari VS, "Phytoestrogens for menopausal bone loss and climacteric symptoms", J Steroid Biochem Mol Biol, 139, pp.294~301 (2014)
84. Hallström H, "Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women", Osteoporos Int, 17, pp.1055~1064 (2006)
85. Chen Z, "Habitual tea consumption and risk of osteoporosis : a prospective study in the womenʼs health initiative observational cohort", Am J Epidemiol, 158, pp.772~781 (2003)
86. Abrahamsen B, "A review of lifestyle, smoking and other modifiable risk factors for osteoporotic fractures", Bonekey Rep, 3, pp.574~ (2014)
87. Maurel DB, "Alcohol and bone : review of dose effects and mechanisms", Osteoporos Int, 23, pp.1~16 (2012)
88. Kemmler W, "Effects of exercise on fracture reduction in older adults : a systematic review and metaanalysis", Osteoporos Int, 24, pp.1937~1950 (2013)
89. Management of menopausal women, "Korean Society of Menopause", Korean Society of Menopause, ~ (2020)
90. Howe TE, "Exercise for preventing and treating osteoporosis in postmenopausal women", Cochrane Database Syst Rev, (7), pp.CD000333~ (2011)
91. Granacher U, "The importance of trunk muscle strength for balance, functional performance, and fall prevention in seniors : a systematic review", Sports Med, 43, pp.627~641 (2013)
92. Sherrington C, "Effective exercise for the prevention of falls : a systematic review and meta-analysis", J Am Geriatr Soc, 56, pp.2234~2243 (2008)
93. Choi M, "Effectiveness of intervention programs in preventing falls : a systematic review of recent 10 years and metaanalysis", J Am Med Dir Assoc, 13, pp.188~ (2012)
94. Gillespie LD, "Interventions for preventing falls in older people living in the community", Cochrane Database Syst Rev, 2012, pp.CD007146~ (2012)
95. Cosman F, "Clinicianʼs guide to prevention and treatment of osteoporosis", Osteoporos Int, 25, pp.2359~2381 (2014)

관련 논문AI추천